End-of-day quote
Korea S.E.
18:00:00 2024-07-01 EDT
|
5-day change
|
1st Jan Change
|
2,130
KRW
|
-1.16%
|
|
+0.47%
|
-11.62%
|
2023 |
NEXTURNBIOSCIENCE Co., Ltd. announced that it has received KRW 7 billion in funding from Flask Co., Ltd., GLK Equity Investment Co., Ltd., SAMSUNG PHARM. Co., LTD., CMG Pharmaceutical Co., Ltd.
|
CI
| 2023 |
NEXTURNBIOSCIENCE Co., Ltd. announced that it expects to receive KRW 9 billion in funding from Flask Co., Ltd., GLK Equity Investment Co., Ltd., SAMSUNG PHARM. Co., LTD., CMG Pharmaceutical Co., Ltd.
|
CI
|
|
2024-06-26
|
2024-06-27
|
2024-06-28
|
2024-07-01
|
2024-07-02
|
Last |
2135 ₩
|
2145 ₩
|
2135 ₩
|
2155 ₩
|
2130 ₩
|
Volume |
627 367 |
283 321 |
185 472 |
237 081 |
169 434 |
Change |
+0.47%
|
+0.47%
|
-0.47%
|
+0.94%
|
-1.16%
|
Opening |
2,125.00 |
2,140.00 |
2,135.00 |
2,125.00 |
2,155.00 |
High |
2,175.00 |
2,150.00 |
2,145.00 |
2,155.00 |
2,160.00 |
Low |
2,120.00 |
2,120.00 |
2,115.00 |
2,120.00 |
2,125.00 |
Avg. Volume 20 sessions
297 317
Avg. Volume 20 sessions KRW
633 285 210.00
Avg. Volume 20 sessions USD
457 231.92
Record volume 1
102 949 900
Record volume 2
81 278 730
Record volume 3
80 941 210
Capital turnover ratio
0.00
Capitalization (KRW)
299 635 462 604
Capitalization (USD)
216 336 804
Net sales (KRW)
93 906 675 100
Net sales (USD)
67 800 619
Sales / Employee (KRW)
339 013 268
Sales / Employee (USD)
244 768
Free-Float capitalization (KRW)
222 198 101 962
Free-Float capitalization (USD)
160 427 030
Average Daily Capital Traded
0.21%
Moving average 5 days
2 140.00
Moving average 20 days
2 140.00
Moving average 50 days
2 117.10
Moving average 100 days
2 169.85
Price spread / (MMA5) +0.47% Price spread / (MMA20) +0.47% Price spread / (MMA50) -0.61% Price spread / (MMA100) +1.87%
More charts
|